WSJ STUDIES PBMs'MAIL-ORDER BUSINESS FOR GENERICS

JUNE 01, 2006

The Wall Street Journal (WSJ) examined how pharmacy benefit managers (PBMs) have managed to grow into "a hugely lucrative place in the food chain" of prescription drug sales, because they "have figured out how to use mail order to turn generics into a bonanza." The 3 largest PBMs—Medco Health Solutions, Caremark Rx, and Express Scripts—reported almost $2 billion in combined profits last year. Generics made up more than half of Medco's mail-order earnings.

According to the WSJ, the PBMs buy generic drugs in bulk for pennies a pill and then charge employers significantly more. For example, in a court case in Ohio, Medco paid $90 for enough pills to fill 114 prescriptions for a generic version of Valium (diazepam) but charged the Ohio State Teachers Retirement System $1028 for the medicine. Many employers, however, still consider the trade-off "a bargain, because [prices of generics are] generally still much lower than those of brand name drugs," the WSJ reports.

The PBMs maintain that the amount they charge employers is necessary to cover overhead costs and smaller profit margin losses for branded drugs. Some states have recently considered legislation that would require PBMs to disclose the sources of their earnings.




SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.